A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

Study suggests inability to identify blood in urine may delay diagnosis and reduce surviva ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...